104 related articles for article (PubMed ID: 12428787)
1. Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma.
Niimi C; Goto H; Ohmiya N; Niwa Y; Hayakawa T; Nagasaka T; Nakashima N
Am J Clin Pathol; 2002 Nov; 118(5):683-92. PubMed ID: 12428787
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
[TBL] [Abstract][Full Text] [Related]
3. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer.
Inadomi T; Tan M; Suzuki H; Shigematsu C
Eur J Dermatol; 1999; 9(3):214-7. PubMed ID: 10210788
[TBL] [Abstract][Full Text] [Related]
6. Analysis of p53 expression in precancerous and malignant gastric mucosa.
Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.
Matturri L; Biondo B; Cazzullo A; Colombo B; Giordano F; Guarino M; Pallotti F; Turconi P; Lavezzi AM
Anticancer Res; 1998; 18(4B):2819-25. PubMed ID: 9713468
[TBL] [Abstract][Full Text] [Related]
8. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
Ishii HH; Gobe GC; Ebihara Y
Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
[TBL] [Abstract][Full Text] [Related]
9. High incidence of nuclear accumulation of p53 protein in gastric cancer.
Uchino S; Noguchi M; Hirota T; Itabashi M; Saito T; Kobayashi M; Hirohashi S
Jpn J Clin Oncol; 1992 Aug; 22(4):225-31. PubMed ID: 1279244
[TBL] [Abstract][Full Text] [Related]
10. The immunohistochemical profile of the adenocarcinoma of upper gastric pole.
Mărgăritescu C; Mogoantă L; Mănescu P; Simionescu C; Pirici D; Streba L; Mercuţ D
Rom J Morphol Embryol; 2007; 48(3):215-35. PubMed ID: 17914488
[TBL] [Abstract][Full Text] [Related]
11. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
12. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in different gastric lesions and gastric cancer: relationship with Helicobacter pylori, overexpression of p53 and aneuploidy.
Targa AC; César AC; Cury PM; Silva AE
Genet Mol Res; 2007 Sep; 6(3):554-65. PubMed ID: 17985308
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
15. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
16. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
Calabrese C; Pisi A; Di Febo G; Liguori G; Filippini G; Cervellera M; Righi V; Lucchi P; Mucci A; Schenetti L; Tonini V; Tosi MR; Tugnoli V
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1386-95. PubMed ID: 18559553
[TBL] [Abstract][Full Text] [Related]
17. Influence of H. pylori infection and eradication on p53, c-erbB-2 and Ki-67 in gastric mucosa.
Brajsa K; Ferencic Z; Katicic M; Radosevic S; Presecki V; Spaventi R; Dominis M
Hepatogastroenterology; 2006; 53(72):968-72. PubMed ID: 17153465
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the immunohistochemical detection of p53 protein in endoscopic biopsy specimens.
Jiang H; Han P; Jiang Y; Liang X; Hu C; Yang D
Chin Med J (Engl); 1997 Mar; 110(3):202-5. PubMed ID: 9594341
[TBL] [Abstract][Full Text] [Related]
19. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
20. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
Heeren PA; Kloppenberg FW; Hollema H; Mulder NH; Nap RE; Plukker JT
Anticancer Res; 2004; 24(4):2579-83. PubMed ID: 15330218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
